China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Teprotumumab N01 Injection in Patients with Thyroid Eye Disease Refractory t... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects and Underlying Mechanisms of Personalized Music Interventions for Depressive Sym... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening for non-alcoholic fatty liver disease and intervention therapy with growth hor... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, multi-center Phase III clinical trial to evaluate the diagnostic efficacy,... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The influence of removing the posterior cruciate ligament on the flexion and extension g... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Assessment of Magnesium Nutritional Status in the Chinese Elderly Population and Dose-Re... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of TACE Combined with Tislelizumab or TACE Alone After Curative Rese... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Neuromodulatory Effects of Low-Intensity Transcranial Focused Ultrasound (t... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimizing Syphilis Diagnosis Algorithm Using Chemiluminescence Assay: A Retrospective R... Read More
China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'PK、PD and safety study of depemokimab (GSK3511294) in paediatric participants (6-11 year... Read More